• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荷兰基本健康保险中的选择激励:临终支出在多大程度上为选择性群体的可预测盈亏做出贡献?

Selection Incentives in the Dutch Basic Health Insurance: To What Extent Does End-of-Life Spending Contribute to Predictable Profits and Losses for Selective Groups?

机构信息

Erasmus University Rotterdam, The Netherlands.

出版信息

Med Care Res Rev. 2022 Dec;79(6):819-833. doi: 10.1177/10775587221099731. Epub 2022 Jun 8.

DOI:10.1177/10775587221099731
PMID:35677989
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9606011/
Abstract

Existing risk-equalization models in individual health insurance markets with premium-rate restrictions do not completely compensate insurers for predictable profits/losses, confronting insurers with risk selection incentives. To guide further improvement of risk-equalization models, it is important to obtain insight into the drivers of remaining predictable profits/losses. This article studies a specific potential driver: end-of-life spending (defined here as spending in the last 1-5 years of life). Using administrative ( = 16.9 m) and health survey ( = 384 k) data from the Netherlands, we examine the extent to which end-of-life spending contributes to predictable profits/losses for selective groups. We do so by simulating the predictable profits/losses for these groups with and without end-of-life spending while correcting for the overall spending difference between these two situations. Our main finding is that-even under a sophisticated risk-equalization model-end-of-life spending can contribute to predictable losses for specific chronic conditions.

摘要

现行的个人医疗保险市场中存在保费费率限制的风险均衡模型并不能完全弥补保险公司可预见的损失/收益,这使保险公司面临风险选择激励。为了进一步完善风险均衡模型,了解可预见的损失/收益的驱动因素非常重要。本文研究了一个特定的潜在驱动因素:临终支出(这里定义为生命最后 1-5 年的支出)。利用荷兰的行政(=1690 万)和健康调查(=38.4 万)数据,我们考察了临终支出在多大程度上导致了选择性群体的可预见的损失/收益。我们通过在纠正这两种情况下总支出差异的同时,模拟这些群体有和没有临终支出时的可预见的损失/收益来做到这一点。我们的主要发现是,即使在一个复杂的风险均衡模型下,临终支出也可能导致特定慢性病的可预见损失。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/9606011/519f697484de/10.1177_10775587221099731-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/9606011/054a87f12e06/10.1177_10775587221099731-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/9606011/2d4d84867694/10.1177_10775587221099731-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/9606011/fb2b1e02d464/10.1177_10775587221099731-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/9606011/519f697484de/10.1177_10775587221099731-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/9606011/054a87f12e06/10.1177_10775587221099731-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/9606011/2d4d84867694/10.1177_10775587221099731-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/9606011/fb2b1e02d464/10.1177_10775587221099731-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/9606011/519f697484de/10.1177_10775587221099731-fig4.jpg

相似文献

1
Selection Incentives in the Dutch Basic Health Insurance: To What Extent Does End-of-Life Spending Contribute to Predictable Profits and Losses for Selective Groups?荷兰基本健康保险中的选择激励:临终支出在多大程度上为选择性群体的可预测盈亏做出贡献?
Med Care Res Rev. 2022 Dec;79(6):819-833. doi: 10.1177/10775587221099731. Epub 2022 Jun 8.
2
Heteroscedasticity of residual spending after risk equalization: a potential source of selection incentives in health insurance markets with premium regulation.风险均衡后剩余支出的异方差性:保费监管下医疗保险市场中选择激励的潜在来源。
Eur J Health Econ. 2024 Apr;25(3):379-396. doi: 10.1007/s10198-023-01592-9. Epub 2023 May 10.
3
Predictable profits and losses in a health insurance market with risk equalization: A multiple-contract period perspective.风险均等化下健康保险市场中可预测的利润与损失:多合同期视角
Health Policy. 2023 May;131:104763. doi: 10.1016/j.healthpol.2023.104763. Epub 2023 Mar 8.
4
Improving diagnosis-based cost groups in the Dutch risk equalization model: the effects of a new clustering method and allowing for multimorbidity.改进荷兰风险均等化模型中的基于诊断的费用分组:一种新聚类方法和允许多病共存的影响。
Int J Health Econ Manag. 2023 Jun;23(2):303-324. doi: 10.1007/s10754-023-09345-0. Epub 2023 Mar 2.
5
Examining unpriced risk heterogeneity in the Dutch health insurance market.考察荷兰健康保险市场中未定价风险的异质性。
Eur J Health Econ. 2018 Dec;19(9):1351-1363. doi: 10.1007/s10198-018-0979-x. Epub 2018 Apr 18.
6
Incorporating self-reported health measures in risk equalization through constrained regression.通过约束回归将自我报告的健康措施纳入风险均等化。
Eur J Health Econ. 2020 Jun;21(4):513-528. doi: 10.1007/s10198-019-01146-y. Epub 2020 Jan 8.
7
High-risk pooling for mitigating risk selection incentives in health insurance markets with sophisticated risk equalization: an application based on health survey information.高风险池在医疗保险市场中缓解复杂风险均衡的风险选择激励:基于健康调查信息的应用。
BMC Health Serv Res. 2024 Mar 4;24(1):273. doi: 10.1186/s12913-024-10774-x.
8
Selection Incentives for Health Insurers in the Presence of Sophisticated Risk Adjustment.存在复杂风险调整时,对健康保险公司的选择激励。
Med Care Res Rev. 2020 Dec;77(6):584-595. doi: 10.1177/1077558719825982. Epub 2019 Feb 1.
9
A new prevention paradox: the trade-off between reducing incentives for risk selection and increasing the incentives for prevention for health insurers.新的预防悖论:健康保险公司减少风险选择激励和增加预防激励之间的权衡。
Soc Sci Med. 2013 Jan;76(1):150-8. doi: 10.1016/j.socscimed.2012.10.019. Epub 2012 Nov 3.
10
Risk equalization in competitive health insurance markets: Identifying healthy individuals on the basis of multiple-year low spending.竞争性健康保险市场中的风险均衡:基于多年低支出识别健康个体。
Health Serv Res. 2019 Apr;54(2):455-465. doi: 10.1111/1475-6773.13065. Epub 2018 Oct 16.

本文引用的文献

1
Incorporating self-reported health measures in risk equalization through constrained regression.通过约束回归将自我报告的健康措施纳入风险均等化。
Eur J Health Econ. 2020 Jun;21(4):513-528. doi: 10.1007/s10198-019-01146-y. Epub 2020 Jan 8.
2
Selection Incentives for Health Insurers in the Presence of Sophisticated Risk Adjustment.存在复杂风险调整时,对健康保险公司的选择激励。
Med Care Res Rev. 2020 Dec;77(6):584-595. doi: 10.1177/1077558719825982. Epub 2019 Feb 1.
3
Predictive modeling of U.S. health care spending in late life.
预测美国老年人医疗保健支出的模型。
Science. 2018 Jun 29;360(6396):1462-1465. doi: 10.1126/science.aar5045.
4
Risk Selection Threatens Quality Of Care For Certain Patients: Lessons From Europe's Health Insurance Exchanges.风险选择危及特定患者的医疗质量:来自欧洲医疗保险交易所的教训。
Health Aff (Millwood). 2015 Oct;34(10):1713-20. doi: 10.1377/hlthaff.2014.1456.
5
Risk selection in a regulated health insurance market: a review of the concept, possibilities and effects.受监管的健康保险市场中的风险选择:概念、可能性及影响综述
Expert Rev Pharmacoecon Outcomes Res. 2013 Dec;13(6):743-52. doi: 10.1586/14737167.2013.841546.
6
Risk equalization in The Netherlands: an empirical evaluation.荷兰的风险均等化:实证评估
Expert Rev Pharmacoecon Outcomes Res. 2013 Dec;13(6):829-39. doi: 10.1586/14737167.2013.842127. Epub 2013 Nov 1.
7
Preconditions for efficiency and affordability in competitive healthcare markets: are they fulfilled in Belgium, Germany, Israel, the Netherlands and Switzerland?竞争性医疗保健市场中效率和可负担性的前提条件:在比利时、德国、以色列、荷兰和瑞士是否得到满足?
Health Policy. 2013 Mar;109(3):226-45. doi: 10.1016/j.healthpol.2013.01.002. Epub 2013 Feb 8.
8
Health care costs during the last 12 months of life in Israel: estimation and implications for risk-adjustment.以色列生命最后12个月的医疗保健费用:估计及其对风险调整的影响。
Int J Health Care Finance Econ. 2010 Sep;10(3):257-73. doi: 10.1007/s10754-010-9080-4. Epub 2010 May 22.
9
Predictability and predictiveness in health care spending.医疗保健支出的可预测性和预测能力。
J Health Econ. 2007 Jan;26(1):25-48. doi: 10.1016/j.jhealeco.2006.06.004. Epub 2006 Aug 14.
10
Health care costs in the last year of life--the Dutch experience.生命最后一年的医疗保健费用——荷兰的经验。
Soc Sci Med. 2006 Oct;63(7):1720-31. doi: 10.1016/j.socscimed.2006.04.018. Epub 2006 Jun 14.